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Cell-mediated immune responses have been shown to play an important role in the 
rejection of tumors and in tumor immunity (see reference  1 for review). Among the 
immune responses to a  tumor graft, cytolytic T  lymphocytes capable of destroying 
target cells  carrying the relevant tumor-associated antigens have been demonstrated 
in  experimental  animals.  In the  Moloney murine sarcoma virus  (M-MSSO 1 system 
that has been extensively studied, M-MSV-induced tumors have been shown to have 
common antigens related to those induced by some murine leukemia viruses (MuLV) 
(2-5).  Although  cell-mediated  immune  responses  induced  by  M-MSV  have  been 
extensively studied by many different techniques, such as the microcytotoxicity test, 
51Cr-release cytotoxicity assay and migration inhibitory factor (MIF) assay, there have 
been no conclusive indications about the antigens recognized by immune T  lympho- 
cytes (see reference 6 for review). 
Recently, some studies  with  lymphocytes from M-MSV-immune mice have sug- 
gested that the recognition of type C  virion proteins appears to account for at least a 
part of the immune reactivity. Enjuanes et al.  (7) demonstrated that the type-specific 
envelope antigen, gp70, of Moloney murine leukemia virus (M-MuLV) could stimu- 
late lymphoproliferative responses by M-MSV-immune lymphocytes and could spe- 
cifically inhibit  cell-mediated cytotoxicity. A  study in  our laboratory has  indicated 
that gp70, p12, and p30 of M-MuLV could also stimulate M-MSV-immune lympho- 
cytes to produce MIF.  z 
Initially,  Plata et  al.  (8)  and  subsequently we  (9,  10)  reported  that  a  secondary 
cytotoxic response could be induced in vitro by incubating spleen cells  from M-MSV 
immune animals with intact  tumor cells.  More recently, we also demonstrated that 
macrophages functioned as accessory cells for the generation of a secondary cytotoxic 
response even when intact tumor cells were used as an antigen (10). This has led to a 
modified procedure for generating a  secondary cytotoxic response, which facilitates 
i Abbreviations used in this paper: DMEM, Dulbecco's  modified Eagle's minimal essential medium; FCS, 
fetal calf serum; FEF, feline embryo  fibroblast; FeLV, feline leukemia virus; FIU, focus-inducing  units; F- 
MuLV, Friend murine leukemia virus; ISC, immune spleen cells; MEF, mouse embryo fibroblast; MIF, 
migration inhibitory factor; M-MSV, Moloney  strain ofmurine sarcoma  virus; M-MuLV,  Moloney  murine 
leukemia virus; MuLV, murine leukemia virus(s); NSC, normal spleen cells; R-MuLV, Rauscher murine 
leukemia virus. 
2  Ng, A.-K., R. S. Ames, Jr.,  R. K. McIntire, and R. B. Herberman. 1979. In vitro studies of cell- 
mediated immunity to Moloney  leukemia virus and Moloney  leukemia-associated antigens. Cancer Res. In 
press. 
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TABLE  I 
Characteristics of the  Tumors and Cell Lines Used in 51Chromium-release Assay 
Cells  Strain of  H-2 hap-  Inducing agent  Condition  Reference 
origin  lotype 
MBL-2  B6  b  Moloney-MuLV(M-MuLV)-induced  lym-  TC*  3 
phoma 
RBL-5  B6  b  Rauscher-MuLV(R-MuLV)-induced  lyre-  TC  3 
phorna 
EL-4(G-)  B6  b  Benzo[alpyrene-induced  lymphoma GCSA-  Ascites  3 
EL-4(G+)  B6  b  Benzo[aJpyrene-lnduced  lymphoma GCSA+  Ascites  3 
EdG2  B6  b  Gross-MuLV-induced lymphoma GCSA+  Spleen  3 
B6-MEF  B6  b  Uninfected horn a  n ouse embryo fibroblast  TC  7 
B6-MEF-M-MuLV  B6  b  M-MuLV-infected  B6-MEF  TC  7 
B6-MEF-F-MuLV  B6  b  Friend-MuLV(F-MuLV)-in fected B6-MEF  TC  7 
B6-MEF-M-MSV  B6  b  M-MSV-in  leered B6-MEF  TC  7 
B6-MEF-B-tropic  B6  b  B-tropic MuLV-infected  B6-MEF  TC  7 
LSTRA  BAI.B/c  d  M-MuLV-induced  lymphoma  TC  3 
RIll  BALB/c  d  Radiation-induced  leukemia  TC  3 
YAC-I  A  a  M-MuLV-induced  lymphoma  TC  3 
RDM-4  AKR  k  Spontaneous lymphoma  TC  I I 
* Tissue culture. 
the examination of the specificity of M-MSV-immune  cytolytic T  lymphocytes.  In 
the present report, we describe our finding that infectious type C  virus can induce a 
secondary  cytotoxic  response,  and  explore  the  possibility that  this  technique  can 
further be used to elucidate the specificity of cytotoxic T  lymphocytes. 
Materials  and  Methods 
Mice.  C57BL/6N  (B6)  mice  were  obtained  from  the  Rodent  and  Rabbit  Production 
Section, Division of Research Services, National Institutes of Health, Bethesda, Md. 
Tumors.  Primary tumors were induced by the M-MSV  (>104 focus-forming units)  in B6 
mice as  described previously (2).  Usually, the  tumors  arose 6-7  after inoculation, reached 
maximum  size on  days  11-14,  and  regressed by  days 22-25.  For studies of the  secondary 
cytotoxic response, spleen cells were obtained from mice 30-50 d  after inoculation with M- 
MSV. 
Target  Cells.  The characteristics and  origins of the cell lines employed in  this study are 
given in Table I (3, 7,  11). They were grown as stationary suspension or monolayer cultures in 
RPMI-1640 medium (Grand Island Biological Co., Grand Island, N.Y.) containing 10% fetal 
calf serum  (FCS),  I00 #g/ml  streptomycin,  100  U/ml  penicillin, and  50 #g/ml  gentamicin 
(hereafter referred to as RPMI-1640-10%  FCS)  (12).  The in vivo passaged tumor lines were 
maintained by serial passage in normal histocompatible recipients. The respective cell lines 
were assayed for the expression of viral antigens by competition radioimmunoassay (7). 
Viruses.  M-MSV was prepared from a  stock originally obtained from Dr. J.  B.  Moloney, 
National  Cancer  Institute  (NCI),  Bethesda,  Md.,  and  maintained  in  our  laboratory  (2). 
Moloney MuLV clone IC  (M-MuLV clone IC)  from  NIH/3T3  cells, Rauscher  MuLV  (R- 
MuLV) from JLS-V9 cells, Gross-MuLV and BALB virus- 1 from NIH/3T3 cells, AKR-MuLV 
from  AKR  mouse embryo fibroblasts (originally obtained  from  Dr.  W.  P.  Rowe,  National 
Institute of Allergy and  Infectious Diseases  [NIAID], Bethesda,  Md.),  BALB  virus-2  from 
human A673 cells, feline leukemia virus (FeLV), and baboon type C virus were obtained from 
the Viral Oncology Program of the National Cancer Institute through the courtesy of Dr. J. 
Gruber. These viruses, except for M-MSV, were purified by double sucrose density gradient 
uhracentrifugation and  stored at  -70°C  until use.  Ecotropic M-MuLV clone H, originally 
isolated by Dr. Janet Hartley, NIAID, Bethesda, Md.  (13),  and a  variant (duahropic) of M- 
MuLV clone 83  (13), both propagated on 3T3FL cells in McCoy 5A medium containing 10% 
FCS, were obtained from Dr. Alan Rein, NCI, Bethesda, Md. A nondefective duahropic virus 
(HIX virus) from M-MuLV clone IC was propagated on feline embryo fibroblast (FEF) (HIX- 
FEF) or human RD cells (HIX-RD) and was obtained from P. J.  Fischinger, NCI, Bethesda, T. TANIYAMA AND H.  T.  HOLDEN 
TABL~ II 
Characterization of Viruses Used in the Present Study 
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Virus parti-  FIU/ml.~  Condition 
Virus  Cell line  Tropism  cles/ml*  used 
M-MuLV clone IC  N1H/3T3§  NB  1.5 ×  l0 n  I ×  l0  s  Purifiedll 
M-MuLV clone H  3T3FL¶  NB  N.D.  2 X  105  Supernate** 
M-MuLV clone 83  3T3FL¶  Dualtropic  N.D.  4 ×  105  Supernate 
HIX-FEF  FEF:~:~  Dualtropic  N.D.  5 ×  105  Supernate 
HIX-RD  RD human cells~:~  Dualtropic  N.D.  5 ×  105  Supernate 
R-MuLV  JL.S-vg~  NB  1 ×  101`2  21 X  107  Purified 
Gross-MuLV passage A  NIH/3T3§  N  2.5 ×  l0  II  I  ×  10  ~  Purified 
AKR-MuLV  AKR-MEF§  N  2.2 ×  10 Ix  5 ×  10  r  Purified 
BALB virus-I BC194  N1H/3T3§  N  1.2 x  l0 II  4 ×  107  Purified 
BALB B-tropic  SC- I§§  B  ND  3 X  106  Supernate 
WNI802B 
BALB virus-2 BC177  A673 human cells§  Xenotropic  1.3 ×  l011  7 ×  l0  n  Purified 
Feline LV Theilen  FL-74§  3.5 X  l011  4 ×  106  Purified 
Baboon type C  M7  A207 human cells§  2.0 x  l0 n  3 x  l0  s  Purified 
* Determined by electron  microscopy. 
:~ Focus-inducing units per milliliter in S+L-  FG-10 assay, S+I,-- mink cell or S+L-  cat 81 cell assay. 
§ Obtained from Dr. J. Gruber, National Cancer Institute, Bethesda. 
[1 Purified by double-density gradient ultracentrifugation. 
¶ Obtained  from Dr. A. Rein, National Cancer Institute, Bethesda. 
** 24-hour supernate  from the relevant confluent culture. 
:~ Obtained from Dr. P. Fischinger, National Cancer  Institute, Bethesda. 
§§ Obtained from Dr. R. Bassln, National Cancer Institute, Bethesda. 
Md.  (14). BALB B-tropic virus (WN  1802B), originally isolated by Dr. Janet  Hartley, was 
propagated on SC-1 cells in McCoy's 5A medium containing 10% FCS and was obtained from 
Dr.  Robert H.  Bassin,  NCI, Bethesda, Md.  (15). The characteristics of the virus used in the 
present study are given in Table II. 
Irradiation of Virus with  Ultraviolet (UV)-light.  Irradiation of infectious virus with UV-light 
(General  Electric  Co.,  Lamp  Parts  &  Equipment  Sales  Operation,  Cleveland, Ohio)  was 
performed as described previously (16). In brief, virus was diluted in 1 ml of phosphate-buffered 
saline, placed onto a  watch glass, and then irradiated with UV-light at 60 ergs/mm  2 per s. 
Treatment for 40 s (total 2,400 ergs/mm  2) was shown to inactivate 1 log of infectious virus, as 
determined by XC syncytial plaque assay (16) and the S+L- focus assay on FG-10 (17). 
Virus Infectivity Assay.  Eeotropic and dualtropic M-MuLVs were assayed according to the 
method of Bassinet al. (17), using the S +  L -  focus assay on FG-10 cells (kindly provided by 
Dr.  R.  Bassin,  NCI)  that  had  been  pretreated  with  20  ~g/ml  DEAE-dextran. Assays  for 
xenotropic virus, FeLV, and baboon type C virus were done by the focus assay in the S +  L 
-  mink cells  (18) (kindly given by Dr. J.  Hartley, NIAID) or the S +  L  -  cat cell 81  (19) 
(obtained from Dr. P. Fischinger, NCI) in the presence of polybrene (2 pg/ml). The results of 
the S +  L -  assay are given as focus-inducing units (FIU) per milliliter. M-MSV was titrated 
on 3T3FL (given by Dr. A. Rein, NCI) in the presence of an optimal concentration of helper 
virus, by the method of Bassinet al. (20), with the titer being expressed  as focus-forming units 
per milliliter. 
In Vitro Generation of a Secondary Cytotoxic Response.  Spleens were removed aseptically from M- 
MSV-immune or normal animals and minced. The resulting single cell suspension was passed 
through  sterile  gauze  and  suspended  in  Dulbecco's  modified  minimal essential  medium 
(DMEM)  containing 10%  FCS  (lot  RG1808, Reheis Chemical Co.,  Chicago, Ill.)  50/.tM  2- 
mercaptoethanol, 2 mM glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin, 34/~g/ml 
L-asparagine,  116  /~g/ml  arginine-HCl, and  10  pg/ml  folic  acid  (hereafter  referred  to  as 
complete  DMEM).  Secondary  cell-mediated  eytotoxicity  was  generated  in  vitro  using  a 
modification of the method described by Plata et al. (8). Briefly, unseparated immune spleen 
cells (ISC),  suspended in complete DMEM, were adjusted to a final concentration of 5 ×  106 
cells/ml. Tumor cells to be used as stimulators were treated with 100/xg/ml mitomycin C/10 7 
cells (Sigma Chemical Co.,  St.  Louis, Mo.)  for 60 min at 37°C and washed three times with 
RPMI-1640-10% FCS.  For culture, 5  ×  l0  s immune spleen cells  were mixed with different 1370  MURINE  LEUKEMIA VIRUS-INDUCED CYTOTOXICITY 
concentrations of purified virus, tissue culture supernates containing infectious virus or 2 ×  105 
mitomycin C-treated tumor cells in 2.0 ml of complete DMEM and dispensed in muhiwell 
dishes  (FB-16-24-TC, Linbro Chemicals, Hamden, Conn.). In a  preliminary experiment, we 
found that with intact tumor cells as in the stimulus, the optimal responding cell to stimulator 
cell ratios were  25:1  and 20:1.  Each group consisted of at least four cultures. Cultures were 
incubated at 37°C in a humidified atmosphere containing 5% CO2 in air. After 5 d in culture, 
lymphocytes were harvested and used as effector cells in a 4-h 51Cr-release assay. 
SICr-release Assay.  The procedure  was  described previously (9,  10). Varying numbers of 
effector cells were mixed with 5 ×  10  a 5aCr-labeled target cells in a final 0.2-ml vol in microtiter 
plates with U-shaped wells (Linbro Scientific Co.). The plates were then centrifuged at 65 g for 
2 min and were incubated at 37°C for 4 h. Supernates were then harvested with the Titertek 
Supernatant Collecting System  (Flow  Laboratories,  Inc., Rockville, Md.),  and  the  percent 
cytotoxicity was determined as follows: 
cpm of test supernate -  cpm of autologous control 
% cytotoxicity =  ×  100. 
total cpm incorporated into cells 
% specific cytotoxicity =  % cytotoxicity of immune spleen cells stimulated with an antigen or 
a  supernatant-containing infectious virus -  % cytotoxicity of immune spleen cells  cultured 
alone or with supernate from uninfected cells. 
The percent cytotoxicity of immune spleen cells cultured alone (unstimulated) was 5.0 :!: 4.4 
(mean +  standard deviation) for 20 experiments. An autologous control, with unlabeled target 
cells in place of lymphocytes, was used to measure the spontaneous release.  Each experimental 
group was tested in quadruplicate. 
Elimination  of  T  Lymphocytes.  AKR  anti-C3H, anti-Thyl.2, was  prepared  as  previously 
described (21). To eliminate T  lymphocytes, 10-20 ×  106 effector  cells were incubated with 
undiluted AKR anti-C3H Thyl.2 serum (0.3 ml) for 30 min at room temperature. Next, the 
cells were washed once with RPMI-1640 medium, resuspended in a  1:2 dilution of normal 
rabbit serum  (Grand Island Biological Co.)  (preselected  for  lack of toxicity against  mouse 
lymphocytes) as a source of complement, and incubated for 45 min at 37°C. After being washed 
three times, the cells were then counted and used in the test. 
Results 
Induction  of a Cytotoxic Response:  Tumor Cells vs.  Virus.  As has been reported previously 
(8-10), M-MSV-immune spleen cells could be restimulated in vitro with the relevant 
intact  tumor cells to  produce  a  potent  secondary  cytotoxic  response 5  d  after  the 
initiation of culture (Table III). In addition to the routine use of MBL-2 tissue culture 
cells  as  the  stimulus,  we  decided  to  investigate whether  supernatant  fluids  from 
cultures of MBL-2 could substitute for the intact tumor cells. As shown in Table III, 
the supernate from MBL-2 cultures was as good as or better than intact tumor cells 
for inducing  a secondary response. Normal spleen cells were not stimulated to produce 
a  cytotoxic  response  with  either  MBL-2  or  culture  supernates  from  MBL-2  cells. 
Furthermore, the stimulated immune cells did not react  appreciably or consistently 
against RLc~I, a  target that does not contain cross-reacting antigens. 
These results prompted us to investigate the possibility that a  virus released from 
MBL-2 was responsible for the induction of this response, because the supernate from 
MBL-2  tissue cultures was  found  to  contain >105  FIU/ml  of infectious ecotropic 
MuLV. M-MuLV clone IC was tested for its ability to induce a  secondary cytotoxic 
response.  Addition of 3  ×  109  virus particles per culture stimulated high  levels of 
cytotoxicity in spleen cells from  animals 30  d  after  MSV  inoculation. As with  the 
supernate from  MBL-2,  no cytotoxic  reactivity was  seen when normal spleen cells 
were used as the responders. T.  TANIYAMA AND H.  T.  HOLDEN  1371 
TAnLE  III 
Induction of Secondary Cytotoxic Responses by the Culture Supernate of MBL-2 or by M-MuL V Clone IC 
Percent specific cytotoxicity (- SE) 
Exp.  Responding*  Antigen  Dose  MBL-2  RLS'I 
cells 
50:1~  10:1  50:1 
1  ISC  MBL-2  2 ×  10s§  34.0 (1.8) 
ISC  Supernate-  I ml  46.8 (1.1) 
MBL-2 
NSC  MBL-2  2 ×  l0  s  0 (0.6) 
NSC  Supernate-  1 ml  1.1 (0.5) 
MBL-2 
2  ISC  MBL-2  2 X 105  20.3 (0.3)  10.7 
ISC  M-MuLV  3 ×  10°l]  36.5 (0.8)  29.7 
clone  IC 
NSC  MBL-2  2 X l0  s  0.1 (0.2) 
NSC  M-MuLV  3 X l0  g  0.1 (0.3) 
clone  IC 
17.2 (0.5)  2.8 (0.8) 
37.9 (1.1)  9.3 (0.8) 
0.1 (0.5)  --1.0 (0.4) 
0.3 (0.4)  0.1 (l.0) 
(0.2)  --¶ 
(1.2) 
-0.3 (0.6) 
0.2 (0.7) 
* 5 ×  106 M MSV-immune spleen cells (ISC) or normal spleen cells (NSC) from B6 mice were cultured for 
5 d in 24-well tissue culture plates. After the incubation,  viable lymphocytes were harvested and tested 
for cytolytic activity in a 4-h ~Cr release assay. 
:~ Effector to target cell ratio. 
§ Number of cells per culture. 
II Virus particles per culture. 
¶ Not done~ 
Kinetics of the Generation of Cytolytic  T  Lymphocytes  by M-MuL V.  To  investigate the 
time  course  of the  secondary  cytotoxic  response  induced  by  M-MuLV  clone  IC, 
multiple cultures  of M-MSV  immune  spleen  cells were  stimulated with  either  M- 
MuLV clone IC or MBL-2. At different times after initiation of culture, the responding 
cells were harvested and tested for their cytolytic activity against MBL-2.  As shown 
in Table IV,  significant cytotoxicity was  induced  by M-MuLV  clone IC  by day 4, 
and by day 5 had reached a  peak. Thereafter, the cytotoxicity induced by M-MuLV 
clone  IC  decreased.  These  kinetics  were  comparable  to  those  observed  in  cultures 
containing mitomycin C-treated MBL-2 as the stimulus. 
Nature of the Effector Cells.  Although it has been established that T  lymphocytes are 
the effector cells generated when intact tumor cells are used as the stimulus (8-10), it 
was  important  to  determine  whether  the  effector  cells  generated  in  a  secondary 
cytotoxic response by M-MuLV  clone IC were also T  lymphocytes. To test this, M- 
MSV-immune spleen cells obtained after 5 d of cuhure with M-MuLV  clone IC were 
treated with anti-Thyl.2 plus complement  before assaying their cytolytic activity on 
MBL-2. As shown in Table V, treatment with anti-Thyl.2 plus complement, but not 
complement  alone,  completely abolished  the  cytolytic activity,  indicating that  the 
effector  cells  generated  in  the  secondary  cytotoxic response  by  M-MuLV  were  T 
lymphocytes. Similar results were obtained when tissue culture supernate from MBL- 
2 was used as the stimulus (data not shown). 
Specificity  of  Cytolytic  T  Lymphocytes  Generated  by  Intact  MBL-2  or  M-MuLV  Clone 
IC.  To  determine  the  specificity of the cytolytic T  lymphocytes, a  wide  panel  of 
target cells was employed in a  4-h 51Cr-release assay. As shown in Table VI, cytolytic 
T  lymphocytes generated by M-MuLV  clone IC were capable oflysing MBL-2, RBL- 1372  MURINE LEUKEMIA  VIRUS-INDUCED CYTOTOXICITY 
TABLE IV 
Kinetics of the Seconda~ Cytotoxic Response Induced by M-MuL V or by Intact MBL-2 Cells 
Percent specific cytotoxicity (+ SE)* 
Day of  E/T 
culture  ratio  M-MuLV clone IC  MBL-2 (2 X 105 
(3 X 109 VP/well)~  cells/well) 
4  100:1  28.5 (0.5)  24.9 (0.6) 
30:1  24.6 (0.7)  22.0 (0.5) 
10:1  19.1 (0.7)  16.6 (0.8) 
5  100:1  39.5 (0.6)  34.2 (0.7) 
30:1  32.4 (0.5)  30.6 (0.8) 
10:1  30.3 (0.5)  26.0 (0.6) 
6  100:1  22.9 (0.8)  21.1 (0.7) 
30:1  20.5 (0.6)  18.7 (0.6) 
10:1  16.9 (0.5)  17.3 (0.8) 
*  MBL-2 cells were used as the target. 
~: Virus particles per culture. 
5, and EL-4(G+)  targets very efficiently. In contrast,  the same effector cells failed to 
lyse  significantly  RDM-4,  E~G2,  RLc~I,  LSTRA,  EL-4(G-),  or  YAC  target  cells. 
Similar patterns were obtained when MBL-2 culture supernate or MBL-2 tumor cells 
were employed as the stimulus.  Hence, these results indicate that the antigen(s)  being 
recognized by cytolytic T  lymphocytes is associated with M-MuLV, but unrelated to 
Gross cell surface antigen  (GCSA), because Ec~G2, a syngeneic Gross-MuLV-induced 
lymphoma, was not lysed, and RBL-5 contains Moloney antigens  (gp70 and p12) on 
their cell surface as determined by competition radioimmunoassay (J. N. Ihle. Personal 
communication.).  Furthermore,  the above results were confirmed by using B6-MEF 
infected with a  variety of murine type C  RNA viruses, which were regularly checked 
for viral  contamination  or activation  and  expression  of endogenous  type C  viruses. 
The results  shown in Table VI clearly indicate  that  no cytotoxicity was detected  in 
the  uninfected  or  F-MuLV-  or  B-tropic  MuLV-infected  B6-MEFs  by  cytolytic  T 
lymphocytes  generated  by  M-MuLV  clone  IC  or  intact  MBL-2  cells.  The  same 
effector cells, on the other hand, lysed efficiently M-MSV- or M-MuLV-infected B6- 
MEF, thus indicating that antigenic determinants  which are recognized by cytolytic 
T  lymphocytes, are immunologically specific for the serotype of M-MuLV. 
Consistent  with  previous  reports  (8,  9,  22,  23),  the  cytotoxicity observed  in  the 
present  study  was  H-2  restricted,  because  YAC  and  LSTRA,  M-MuLV-induced 
iymphomas of A  and BALB/c mice were not lysed in a  4 h  5aCr-release assay (Table 
VI). Moreover, the fact that good targets (YAC and RLc~I) for NK activity (24) were 
also not killed  significantly by cytolytic T  lymphocytes shows that  the effector cells 
were immune T  lymphocytes but not NK cells. This result was further confirmed by 
a  cold  target  inhibition  study  in  which  experiments  were  performed  using  labeled 
MBL-2 target  cells  and unlabeled  competitive  inhibitor  cells  including MBL-2 and 
YAC.  Only  MBL-2  inhibitor  cells  abrogated  the  cytolysis  of MBL-2  in  a  dose- 
dependent  manner whereas YAC did not inhibit  (data not shown). 
The Role of the Infectivity of M-MuL V in Induction  of a Secondary  Cytotoxic  Response.  In 
the above experiments, infectious M-MuLV clone IC was shown to induce a secondary 
cytotoxic  response.  It  was  important  to  determine  if  infectivity  was  required  for 
induction of the response,  because previous reports  with other nononcogenic viruses T.  TANIYAMA AND H.  T.  HOLDEN 
TABLE  V 
Effect of Anti- Thy l.2 Plus Complement on Effector Cells Induced by Culture of 
M-MSV-immune Spleen Cells with M-MuL V 
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Percent recovery  Percent specific cyto- 
Treatment  of viable cells  toxicity (± SE)* 
Medium  100  36.3 (1.5) 
C  90  32.9 (1.6) 
Anti-Thyl.2 +  C  35  0 (0.7) 
* Effector to target cell ratio of 60:1, against MBL-2 target cells. 
TABLE  VI 
Specificity of Cytolytic Activity of T Lymphocytes Generated in Response to M-MuL V 
H-2 haplo- 
Target cells  type 
Percent specific cytotoxicity* 
M-MuLV clone  Supernatant-  Intact MBL-2$ 
IC$  MBL-2$ 
MBL-2  b  37.5-60.9§  47.4  21.3 
RBL-5  b  41.3§  22.1  18.5 
EL-4(G+)  b  34.2§  --II  -- 
EL-4(G-)  b  1.2-6.1§  --  1.4-8.8 
EdG2  b  -  1.2-1.0§  --  -- 
YAC  a  1.7§  --  -- 
RLd I  d  2.9-3.9§  1.9  2.4-6.4 
LSTRA  d  0.8§  1.5  4.2 
RDM-4  k  2.6§  --  3.3 
B6-MEF  b  0.2-2.1¶  --  0.1-3.5 
B6-MEF-M-MuLV  b  20.5-25.8¶  --  14.2-16.8 
B6-MEF-M-MSV  b  20.8-28.9¶  --  21.6 
B6-MEF-F-MuLV  b  2.9-4.2¶  --  2.9 
B6-MEF-B-tropic  b  -0.2-3.7¶  --  0.2-0.6 
* Two values indicate the range ofcytotoxicity from multiple tests; one value is percent specific cytotoxicity 
from one experiment. 
:t: Antigen used as stimuli in secondary  responses. 
§ E/T ratios of 30:1-50:1. 
II Not done. 
¶ E/T ratios of 50:1-150:1. 
were conflicting.  Ertl et al.  (25)  reported  a  requirement  for infectious  vaccinia  virus 
to induce virus-specific cytotoxic T  lymphocytes  in vivo. However, inactivated  influ- 
enza virus  (26)  and  Sendai  virus  (27,  28)  were able  to  induce cytotoxic responses  in 
vitro.  Experiments  were  therefore  performed  to  investigate  whether  inactivated  M- 
MuLV  was able to induce a  secondary cytotoxic response against MBL-2. The results 
shown  in  Fig.  1 A  indicated  that  when  the infectious  virus was  exposed  to  UV-light 
for a  period  resulting  in  a  decrease  to  1/1,000  of the original  infectivity,  1,000-fold 
more virus particles were required  to induce the same degree of the cytotoxicity. We 
considered  the possibility that  this treatment  somehow  rendered  the  infectious  virus 
immunologically inactive (e.g., by conformational change of the antigens).  Therefore, 
various  doses  of UV-irradiation  were  tested  and  the  results  are  shown  in  Fig.  1 B. 
Treatment  of the infectious M-MuLV  for 40 s  (2,400  ergs/mm 2) or  1 min 20 s  (4,800 
ergs/mm2),  which  decreased  infectivity  by  1  or  2  logs,  respectively,  decreased  the 1374  MURINE LEUKEMIA VIRUS-INDUCED CYTOTOXICITY 
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Fro.  1.  Effect of UV  irradiation on  the ability of M-MuLV clone  IC to induce  a  secondary 
cytotoxic response. The infectious M-MuLV was irradiated with UV-light  at 7,200 ergs/mm  2 (2 
min, A) (Fig. 1A), which has been shown to decrease infectivity by 3 logs, or at 2,400 (40 s, II) or 
4,800 (1 min 20 s, V) ergs/mm  2 (Fig. 1B), which have been shown to decrease infectivity to 1 or 2 
logs, respectively. The ability of UV-treated M-MuLV to induce a secondary cytotoxic response 
was compared to that of untreated virus (0). MBL-2 cells were used as the target, with an effector 
to target  cell ratio of 100:l. Note  that the ability of M-MuLV to induce a secondary cytotoxic 
response decreased in parallel with the infectivity of M-MuLV. 
ability of the virus to induce a  secondary cytotoxic response by ~  12- to 50-fold and 
100-  to  300-fold, as compared  to the untreated  virus control.  Taken  together,  these 
results suggest  that  there is a  close correlation between  the  infectivity of M-MuLV 
and the ability to induce a  secondary cytotoxic response in this system. 
Specificity  of a  Secondary Cytotoxic  Response  in  the  Induction  Phase.  Having examined 
the specificity of the cytolytic T  lymphocytes induced by M-MuLV  clone IC, it was 
of interest to determine whether other murine leukemia viruses, such as ecotropic and 
xenotropic virus, and nonmurine  type C  viruses, such  as FeLV and  baboon  type C 
viruses, could also induce a  secondary cytotoxic response of M-MSV-immune  spleen 
cells. The results of experiments with an exogenous ecotropic type C  virus (R-MuLV) 
and three endogenous N-tropic and one B-tropic type C  viruses are shown  in Tables 
VII and  VIII.  AKR-MuLV,  Gross-MuLV,  BALB  virus-l, and  B-tropic virus were 
unable  to  induce  a  secondary cytotoxic response  by  M-MSV-immune  spleen  cells, 
even when  the number  of virus particles per culture was varied from  105 up  to  109 . 
M-MuLV  clone  IC, on  the other  hand,  was  consistently capable of inducing  high 
levels of reactivity. Furthermore, no cytotoxic response was detectable against Ec~G2, 
a  Gross-MuLV-induced lymphoma, in the cultures of M-MSV-immune  spleen cells 
and Gross-MuLV or M-MuLV  (data not shown).  However, when M-MSV-immune 
spleen cells were  cultured  with  R-MuLV  (Table VII),  low  but  significant  levels of 
cytotoxicity were detectable. 
Recently, some variants of M-MuLV, which were shown to be recombinants in the 
env  gene  region  between  ecotropic  M-MuLV  and  a  xenotropic  virus,  have  been 
isolated (13,  14). It was of interest to determine whether these variants of M-MuLV 
(M-MuLV clone 83, HIX-FEF, or HIX-RD)  as well as ecotropic M-MuLVs clone IC 
and clone H  could induce a  secondary cytotoxic response by M-MSV-immune  spleen 
cells. The results shown  in Table IX indicate that  two ecotropic M-MuLVs  consist- 
ently showed an ability to induce a secondary cytotoxic response. However, M-MuLV T. TANIYAMA AND H. T.  HOLDEN  1375 
TABLE VII 
Ability of Ecotropic Viruses To Induce a Secondary Cytotoxic Response by M-MSV-immune Spleen Ceils 
Percent  specific cytotoxicity (+ SE)* 
Exp.  Virus:~  Number of virus particles 
10  5  IO  ~  10  7  IO  s  10  ~  I0 x" 
Exp.  1  M-MuLV clone IC  (3 ×)§  2.4 (0.4)  6.4 (0.5)  4.7  (0.8)  18.3 (0.5)  36.8 (0.5)  --]] 
R-MuLV  (2 ×)  --  2.2 (0.8)  2.6 (0.7)  3.8 (0.5)  6.9 (0.4)  5.0 (0.5) 
AKR-MuLV  (4 ×)  0.1  (0.5)  0 (0.7)  0.3 (0.7)  1.0 (0.4)  0 (0.7)  -- 
Exp. 2  M-MuLV clone IC  (3 ×)  0.1  (0.9)  0 (0.7)  1.7 (1.0)  23.1  (I.0)  55.8 (3.0)  -- 
Gross-MuLV  (3 X)  0,8 (1.0)  1.9 (0.7)  4.3 (0.8)  3,3 (0.9)  0 (0.7)  -- 
Exp. 3  M-MuLV clone IC  (I.5 ×)  --  2.0 (0,5)  6.3 (0.6)  16.8 (0.6)  284 (06)  -- 
BALB-virus-I  (I,5  X)  --  0.1  (0,7)  1.0 (0.5)  0 (0.5)  0.2 (0.5)  -- 
* MBL-2 cells were used as a  target. E]T ratio was 80:1 in Exp.  1. 100:1 in Exp. 2 and 80:1 in Exp. 3. 
Purified by double sucrose density gradient. 
§ Number of virus particles per culture is the number in parentheses times the heading of each colunm. 
I] Not done. 
clone 83, HIX-FEF, and HIX-RD were found to be inactive, suggesting that the env 
gene product, gp70, was important in this response. 
Aoki et al. (29)  had reported that SIRC cells infected with some xenotropic viruses 
inhibited  the  cytolysis  by  anti-M-MSV  cytolytic  T  lymphocytes.  Therefore,  an 
experiment employing xenotropic BALB virus-2 was performed. As shown in Table 
X,  BALB  virus-2  was  inactive,  whereas  M-MuLV  clone  IC was  able  to  induce  a 
secondary cytotoxic response in the same experiment. We also evaluated whether type 
C viruses derived from other species could generate a secondary cytotoxic response by 
M-MSV-immune spleen  cells.  The results shown  in Table XI clearly indicate  that 
FeLV and baboon type C viruses were inactive. Taken together, these results strongly 
suggest  that  the  induction  of a  secondary cytotoxic response by M-MSV-immune 
spleen cells was immunologically type specific for M-MuLV. 
Discussion 
Results obtained in the present study indicate that M-MuLV can induce a  strong 
secondary cytotoxic response by M-MSV-immune spleen cells. The specificity of the 
response induced by M-MuLV was the same as that induced by the primary response 
and  the effector cells were shown  to be T  lymphocytes. Although  the supernate of 
tumor cells (MBL-2 in these experiments) stimulated a cytotoxic response as strong as 
that  induced  by the  tumor cells  themselves, it  is  not  clear what  proportion  of the 
response induced by the intact cells can be accounted for by the production of virus. 
First, the concentration of MBL-2 tumor cells that we used to generate the supernate 
was 5- to  10-fold higher than the concentration employed in the secondary response 
culture  and,  therefore,  the  increase  in  cell concentration  could  have yielded higher 
titers of virus in the supernate than are normally produced in the secondary response 
cultures. In addition, we have recently found that infectious virus is most effective at 
inducing  a  secondary  response  when  added  during  the  first  24  h  of culture  (T. 
Taniyama.  Unpublished  observations.).  Therefore,  it  would  be  important  to  have 
high concentrations of virus during the early phase of the in vitro secondary response 
and  further testing would  have to be performed to  determine  whether  the  rate of 
virus production by the tumor cells was sufficient to meet these requirements. Second, 
although LSTRA induces a potent secondary cytotoxic response in syngeneic BALB/ 1376  MURINE  LEUKEMIA VIRUS-INDUCED CYTOTOXICITY 
TABLE VIII 
Inability of B-Tropic Endogenous Type C Virus To Induce a Secondary Cytotoxic Response by 
M-MSV-immune Spleen Cells 
Dose 
Virus  (FIU/well) 
Percent specific cytotoxicity (± SE) vs. 
MBL-2 
100:1"  30:1  10:1 
M-MuLV clone IC  4 ×  106  45.4 (2.1):I:  40.8 (1.6)  39.4 (1.1) 
M-MuLV clone IC  4 ×  105  38.5 (1.3)  36.3 (1.4)  33.5 (1.8) 
M-MuLV clone IC  4 ×  104  25.0 (l.3)  17.2 (0.6)  10.6 (1.2) 
B-tropic virus  4 ×  106  1.0 (0.7)§  0.6 (0.3)  -1.2 (0.4) 
B-tropic virus  2 ×  106  -1.2 (0.3)  -1.2 (0.8)  0.3 (1.2) 
B-tropic virus  1 ×  10  ~  --i.4 (0.4)  0.8 (1.2)  -1.9 (0.7) 
Supernatant-MBL-2  8 x  105  32.6 (1.5)~:  16.7 (0.2)  12.4 (0.3) 
Supernatant-MBL-2  4 ×  105  27.3 (1.2)  14.4 (0.7)  9.6 (0.9) 
* Effector to target cell ratio. 
Specific cytotoxicity was calculated by subtracting percent cytotoxicity of immune cells cultured alone 
from percent cytotoxicity of immune ceils cultured with virus or supernate. 
§ Specific cytotoxicity was calculated by subtracting percent cytotoxicity of immune  cells cultured with 
control-uninfected  supernate  from  the  relevant  cell  line  from  percent  cytotoxicity  of immune  cells 
cultured with the supernate containing the infectious virus. 
c  M-MSV-immune  spleen  cells,  it  does  not  as  readily  stimulate  development  of 
cytotoxicity to tumor-associated antigens in  B6 M-MSV-immune  spleen cells. If the 
virus produced by the tumor cells were the only stimulus, then one might expect the 
same cells to be an equally capable inducer for both responding populations. However, 
MHC  products on the envelope of the released viruses might contribute to differences 
in responses by syngeneic vs. allogeneic responding cells, perhaps by influencing the 
rate at which the virus was adsorbed to the cells. Alternatively, the situation may be 
the  same  as  mentioned  in  the  first  point,  namely  that  there  is  not  enough  virus 
produced  by  the  tumor  cells  (LSTRA  in  this  case)  during  the  early phase  of the 
culture, to act as an efficient stimulus. Regardless of the explanation, it appears that 
the tumor cells are more restricted than  infectious virus in their ability to induce a 
secondary response and also that  the sequence of events after stimulation by tumor 
cells may be different from that when infectious virus is the inducing agent. 
The results in the present study also suggest  that  for virus to be able to induce a 
secondary cytotoxic response, it must  be infectious. When  M-MuLV  was irradiated 
with UV-light at doses which caused a  decrease in infectivity of either  1, 2, or 3 logs 
as determined by the XC-plaque assay, the ability of irradiated M-MuLV  to induce 
a  secondary cytotoxic response decreased in parallel to the infectivity. Although this 
result suggests that  there was an  association between  infectivity of the virus and  its 
ability to induce a  secondary cytotoxic response, at  least two other possible mecha- 
nisms  for this can  be considered.  The  first  is that  the UV  irradiation rendered  the 
virus  immunologically inactive.  Although  this  is  certainly  possible,  it  is  not  likely 
because it has been shown that UV irradiation mainly affected RNA species and not 
proteins  (30).  The  second  alternative is  that  infection with,  and  replication of,  M- 
MuLV, and not just adsorption of virus, was required for the formation of immuno- 
logically active  antigens  on  the  cell  surface.  Although  low  doses  of infectious  M- 
MuLV  could  induce  detectable  cytolytic  T  lymphocytes,  little  cytotoxicity  was 
generated in the presence of 103- to  104-fold higher concentrations of virus that  had T.  TANIYAMA AND  H.  T.  HOLDEN  1377 
TABLE IX 
Ability  of Ecotropic M-MuLVs and Variants (Dualtropic)  of M-MuLV Clone IC To Induce a Secondary 
Cytotoxic Response 
Dose 
Virus  (FlU/well) 
Percent specific cytotoxicity (+ SE) vs. 
MBL-2 
100:1"  70:1  10:1 
M-MuLV clone IC  4 X 106  52.1 (0.8)1:  50.0 (1.9)  34.5 (1.4) 
M-MuLV clone IC  4 x  105  42.3 (1.4)  40.8 (1.0)  27.8 (0.6) 
M-MuLV clone IC  4 x  104  13.2 (0.6)  11.8 (0.5)  8.8 (0.9) 
M-MuLV clone H  2 X 105  30.1 (0.5)§  27.7 (0.6)  21.5 (0.6) 
M-MuLV clone H  4 ×  104  21.6 (0.3)  17.6 (0.4)  15.1 (0.4) 
HIX-FEF  5 X l0  s  2.2 (0.3)§  2.9 (0.5)  2.4 (0.8) 
HIX-FEF  1 x  10  ~  2.5 (0.8)  1.5 (0.7)  1.8 (0.6) 
HIX-RD  5 X 105  1.2 (0.4)§  1.8 (0.1)  0.9 (0.6) 
HIX-RD  1 ×  l0  s  2.0 (0.6)  2.1 (0.9)  1.2 (1.0) 
M-MuLV clone 83  4 X 10  ~  1.5 (1.0)§  2.1 (0.8)  1.5 (0.6) 
M-MuLV clone 83  8 X 104  -1.2 (0.8)  1.3 (0.6)  2.1 (0.8) 
* As in Table VIII. 
:~ As in Table VIII. 
§ As in Table VIII. 
been  UV-irradiated  to  reduce  the  titer  by  7  logs  (data  not  shown).  In  recent 
experiments  using purified  M-MuLV  gp70 (5/~g/ml),  we have been unsuccessful  in 
inducing  a  secondary  cytotoxic  response  (unpublished  data),  although  it  may  be 
possible  to induce  a  response  with  much  higher concentrations  of M-MuLV  gp70. 
Therefore, infectivity of virus appears to be necessary for the induction of a secondary 
cytotoxic response. Our results should be compared to those by Braciale and Yap (26) 
and Others (27, 31). Inactivated Sendai virus or virion proteins were shown to induce 
virus-specific  cytotoxic responses  (27,  28),  and  to  sensitize  target  cells  for  lysis  by 
cytolytic T  lymphocytes  (27,  31).  Braciale  and  Yap  also found that  influenza  virus 
inactivated by UV light was able to induce a  secondary cytotoxic response but failed 
to sensitize target cells for lysis (26). Nevertheless, it should be noted that Sendai virus 
possesses a  fusion protein which allows for the efficient integration of virion antigens 
into cell  surface cytoplasmic membranes  (32).  Thus,  the requirement  for infectivity 
with M-MuLV  suggests that  absorption of the inactivated  virus is not sufficient for 
immunogenicity. It seems likely that integration of M-MuLV into the cell membranes 
of responding  cells  or accessory cells,  via  infection,  is  needed  for the  formation  of 
stimulatory  antigens.  These  results  are  compatible  to  those  of Ertl  et  al.  (25)  and 
Braciale  and  Yap  (26)  who showed  that  infectivity  of viruses  was required  for the 
induction of cytolytic T  lymphocytes in vivo by using vaecinnia and influenza viruses. 
Currently, we are investigating which types of the cells are infected with M-MuLV. 
In some other studies  involving cytotoxic reactivity against  type C  viral antigens, 
it appears that noninfectious materials were capable of inducing an in vitro secondary 
cytotoxic response. Alaba and Law (33) have recently reported that spleen cells from 
mice immunized with antigen solubilized from the plasma membrane of a  Rauscher 
virus-induced  lymphoma could  be  restimulated  in  vitro  with  the  same  antigen  to 
become cytotoxic.  Bruce et  al.  (34)  found that  disrupted  MuLV  could  stimulate  a 
secondary response by spleen  cells  from rats  immunized  with a  Gross virus-induced 
lymphoma.  In  contrast,  we  have  previously  tested  several  materials  (other  than 1378  MURINE LEUKEMIA VIRUS-INDUCED CYTOTOXICITY 
TABLE X 
Failure of a Xenotropic  Virus (BALB  Virus-2)  To Induce a Secondary Cytotoxic Response 
by M-MSV-immune Spleen Cells 
Number of virus 
particles  E/T ratio 
Percent specific cytotoxicity 
(± SE) vs. MBL-2 
M-MuLV  BALB virus-2  clone IC 
3 x  lO  s  100:1  0 (0.6)  2.0 (0.9) 
30:1  0 (0.7)  1.9 (0.7) 
10:1  0 (0.5)  0.6 (0.6) 
3 X  10  7  100:1  t3.8 (I.0)  1.9 (0.7) 
30:1  7.1 (0.9)  0.9 (0.7) 
10:1  3.9 (0.7)  1.9 (0.6) 
3 X lO  s  100:1  34.7 (0.7)  2.2 (l.0) 
30:1  27.2 (1.5)  1.1 (0.9) 
10:t  17.3 (0.8)  2.9 (1.0) 
3 X 109  100:1  41.0 (0.8)  0.5 (0.8) 
30:1  37.0 (1.0)  0 (0.5) 
10:1  25.5 (1.l)  2.I (0.7) 
infectious  virus)  derived  from  MBL-2  tumor  cells  (among  these  were  subcellular 
extracts  obtained  by  freezing  and  thawing,  and  fractions  solubilized  by  NP-40, 
deoxycholate,  and  3M  KC1)  for  their  ability  to  stimulate  a  secondary  cytotoxic 
response by M-MSV-immune spleen cells and found them to be inactive (unpublished 
observations). This may have been a result of insufficient antigenicity of the solubilized 
material  or,  in  light  of the  data  discussed  in  this  paper,  to  insufficient  titers  of 
infections virus in these preparations.  Alternatively, some of the different results that 
have  been  obtained  in  various  studies  may  be  related  to  the  method  of primary 
immunization;  we used  virus  for immunization  whereas  Alaba  and  Law  (33)  used 
soluble antigen and Bruce et al.  (34) employed viable tumor cells. 
Although  tumor  immune  responses  in  the  MSV  system  have  been  extensively 
studied  in  many laboratories,  there  is  no agreement  on the  nature  of the  antigenic 
specificities  of the cellular response.  Gomard et  al.  (23)  examined  the nature  of the 
cell surface antigens, and found that Friend-Moloney-Rauscher-like antigens appeared 
to be major antigenic  determinants.  Herberman  et  al.  (3)  reported  that  the surface 
antigens  recognized  by  anti-M-MSV  cytolytic T  lymphocytes  were  related  to  the 
expression  of endogenous  type C  virus.  Furthermore,  Aoki et  al.  (29),  using  a  cold 
target cell inhibition assay, reported that xenotropic virus-producing SIRC cells could 
inhibit  the anti-M-MSV  response.  Gorczynski and  Knight  (35)  found p30 to be one 
of the  antigenic  determinants.  More  recently,  Enjuanes  et  al.  (7)  found  that  the 
primary  anti-M-MSV  cytotoxic response  was  specific for M-MuLV,  and  especially 
for  its  envelope  gp70,  as  determined  by  ~tCr  release  inhibition  by  purified  virion 
components.  In  the  present  study,  we  examined  the  specificity  of the  cytotoxic 
response  in  both  the  induction  and  effector phases.  Effector cells  generated  by M- 
MuLV clone IC could lyse efficiently MBL-2, EL-4(G+), B6-MEF-M-MSV, and B6- 
MEF-M-MuLV,  but  did  not  significantly  affect  EL-4(G-),  YAC,  RLdl,  RDM-4, 
B6-MEF, B6-MEF-B-tropic, B6-MEF-F-MuLV, and  E(3G2, thus  indicating that  the 
determinant(s)  recognized by cytolytic T  lymphocytes was closely associated with M- 
MuLV but  not with a  variety of other murine type C  oncornaviruses.  These results T. TANIYAMA  AND H.  T.  HOLDEN  1379 
TABLE XI 
Ability of M-MuL V Clone IC or Nonmurine Type C  Viruses To Induce a Secondary Cytotoxic Response by 
M-MSV-immune Spleen Cells 
Exp.  Virus  E/T ratio 
Percent specific cytotoxicity (+ SE) vs. MBL-2 
Number of virus particles 
3X 106  3× 107  3x  10  a  3X 10  a  3× 101° 
M-MuLV clone  80:1  6.2 (0.7)  11.7 (1.0)  31.3  (1.2)  43.7  (1.6)  --* 
IC  30:1  4.2 (1.0)  8.6 (1.6)  26.3  (1.9)  42.3  (0.5)  -- 
FeLV Theilen  80:1  0.7 (0.5)  1.8 (0.6)  1.3 (0.5)  1.6 (0.6)  -- 
30:1  0.3 (0.7)  0 (0.5)  0.3 (0.5)  0.6 (0.7)  -- 
M-MuLV done  50:1  0 (0.7)  1.5 (0.7)  19.4 (0.6)  32.5  (0.9)  41.3  (1.8) 
IC  30:1  0 (0.4)  0.9 (0.7)  0.9 (0.9)  18.3  (0.6)  25.6  (1.3) 
Baboon M7  50:1  0 (0.6)  0 (0.3)  0.1 (0.8)  1.6 (0.5)  2.1 (1.3) 
type C  30:1  0.1 (0.7)  0.7 (0.7)  0.1 (0.8)  1.3 (0.4)  1.4 (0.6) 
*  Not  done. 
support  the  findings  of Cerny  and  Essex  (36)  and  Cloyd et  al.  (37)  showing  that 
Moloney antigens are different from Friend and Rauscher antigens as determined by 
immunofluorescence microscopy. 
The M-MuLV-stimulated  effector cells also  lysed  RBL-5  (induced  by R-MuLV) 
and  EL-4(G+)  targets,  which  would  appear  to  be  against  an  M-MuLV-restricted 
specificity.  However, RBL-5 cells contained a  significant amount of M-MuLV  anti- 
gens  (gp70  and  p12),  as  determined  by  competition  radioimmunoassay  (J.  Lee, 
personal  communication)  and  therefore,  it  is  not  surprising  that  intact  RBL-5  or 
supernate  of RBL-5 were  also  capable  of inducing  a  secondary  cytotoxic  response 
(unpublished  data). The present results with EL-4(G+) are Compatible with previous 
data  from our  laboratory  (3)  indicating  that  these  cells  are  susceptible  to  lysis  by 
primary anti-M-MSV immune cells and can inhibit  the cytolysis of RBL-5 or MBL- 
2 in a  cold target inhibition  assay. Ng et al.  (38)  also have shown that anti-M-MSV 
serum lysed EL-4(G+)  in the presence of complement.  EL-4(G+) cells susceptible to 
the  lysis  by  the  effector  cells  were  shown  to  contain  NB-tropic  and  xenotropic 
endogenous  type  C  viruses  (39).  Thus,  although  EL-4(G+)expresses  serologically 
detectable  GCSA, it  seems possible  that  EL-4(G+)  contains  an endogenous MuLV 
closely associated to M-MuLV, instead of or in addition  to Gross-MuLV. 
In the induction phase, only ecotropic M-MuLVs clone IC and clone H  were able 
to induce a secondary cytotoxic response by M-MSV-immune spleen cells. In contrast, 
AKR-MuLV, Gross-MuLV, BALB-B-tropic virus, and BALB virus-1 failed to induce 
such  responses,  indicating  that  this  response was not  a  result  of these characterized 
endogenous  murine  type  C  viruses.  However,  it  is  still  possible  that  a  particular 
endogenous type C  virus was responsible for the induction of this response. When R- 
MuLV  was used  as the stimulus,  low but  significant  levels of cytotoxicity could be 
induced,  thus  indica~ting some cross-reactivity,  perhaps  of a  minor  antigenic  deter- 
minant(s), between M- and R-MuLVs, because type-, group- and interspecies-specific 
determinants  of gp70 and p30 have been found by radioimmunoassay  (40). Thus, it 
appears  from  the  above  results  that  the  induction  of in  vitro  secondary  cytotoxic 
responses by virus is specific for M-MuLV and related  viruses. 
Because some variants  (M-MuLV clone 83, HIX-FEF, or HIX-RD) of M-MuLV 1380  MURINE  LEUKEMIA VIRUS-INDUCED CYTOTOXICITY 
clone IC have been isolated and characterized as recombinants in the env gene between 
an ecotropic M-MuLV and xenotropic virus (13,  14, 41), we tested for the ability of 
M-MuLV clone 83, HIX-FEF or HIX-RD to induce a secondary cytotoxic response 
by M-MSV-immune spleen cells. The two ecotropic M-MuLV clone IC and clone H 
were able to induce the response, whereas dualtropic M-MuLV clone 83, HIX-FEF, 
and HIX-RD failed to do so, indicating that type-specific determinants of M-MuLV 
gp70 are  important  in  this  system.  It should be  noted  that  when  mouse cells  were 
infected with M-MuLV clone 83 or HIX-FEF, infectious virus was released into the 
supernate, thus indicating that the lack of stimulation by M-MuLV clone 83 or HIX- 
FEF was not a result of an inability to infect mouse cells  (data not shown). 
Thus, by studying the ability of infectious viruses to induce a  secondary response, 
we have found that both the induction and effector phases of the in vitro secondary 
cytotoxic response in the M-MSV system are strongly associated with the type-specific 
determinants  of M-MuLV  gpT0.  Furthermore,  this  experimental  approach  should 
facilitate  the detailed  analysis of the cell-mediated cytotoxic response to oncornavi- 
ruses. 
Summary 
We have developed a  system to induce oncornavirus-specific secondary cytotoxic 
response in vitro. When Moloney strain of murine sarcoma virus-immune spleen cells 
were cultivated with purified infectious Moloney murine leukemia virus (M-MuLV) 
or with supernates of tissue culture cells  containing infectious virus, a  virus-specific 
secondary  cytotoxic  response  directed  against  type-specific  determinant(s)  of  M- 
MuLV was generated in vitro, as determined by a 4-h mCr-release assay. The effector 
cells  were susceptible to the treatment with anti-Thyl.2 plus complement, but were 
unrelated to natural  killer cells  (NK), because they could not lyse some target  cells 
that are highly sensitive to NK activity. This response was primarily (or largely) type- 
specific for M-MuLV in both the induction phase and the interaction between effector 
cells  and target cells.  Furthermore, a  product of the env  gene of M-MuLV, perhaps 
gp70, appeared to be responsible for this response, because viruses with recombinations 
in the env gene between ecotropic M-MuLV and a  xenotropic virus failed to induce 
a response. When infectious M-MuLV was exposed to UV-light at different doses, the 
ability of UV-treated M-MuLV to induce a  secondary cytotoxic response decreased 
in parallel with infectivity, indicating that infectivity was necessary for the induction 
of this response. 
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